OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - AMGEN | Market Closed - Börse Stuttgart 01:18:59 25/05/2024 am IST | ||
| 15.32 EUR | +0.20% |
|
| Current month | -17.59% | ||
| 1 month | -18.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 15.32 | +0.20% |
| 23/24/23 | 15.29 | +3.24% |
| 22/24/22 | 14.81 | +2.49% |
| 21/24/21 | 14.45 | -1.23% |
| 20/24/20 | 14.63 | -0.27% |
Delayed Quote Börse Stuttgart
Last update May 25, 2024 at 01:18 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SW1ZXD |
| ISIN | DE000SW1ZXD2 |
| Date issued | 08/08/2023 |
| Strike | 471.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 21.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.18 € |
|---|---|
| Lowest since issue | 13.66 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
